Actively Recruiting
Pediatric PET/MR Image Registry for Tumor Diagnosis in Children and Young Adults
Led by Stanford University · Updated on 2026-02-09
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
S
Stanford University
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to compare three imaging techniques—whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and, if available, PET/computed tomography (CT) imaging—in diagnosing tumors in children and young adults. The study focuses on assessing differences in sensitivity, specificity, and diagnostic accuracy among these imaging methods for solid tumors and certain leukemia cases with suspected focal lesions. The study is observational and involves participants with proven or suspected solid tumors.
CONDITIONS
Brief Title
Pediatric PET/MR Image Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor
- Some patients with leukemia if there is concern for a focal lesion in any of their organs
- Participant's parents (if participant is under 18) or the participant (if 18 or older) must provide written informed consent prior to image transfer
You will not qualify if you...
- Contraindications for MRI or PET/MR including cardiac pacemakers or intracranial vascular clips
- Blood glucose level higher than 200 mg/dl
- Lack of parental permission (if participant is under 18) or lack of informed consent (if participant is 18 or older)
- Presence of a central nervous system primary tumor
- Pregnant women and fetuses
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants undergo MR imaging, PET/MR imaging, and if available, PET/CT imaging to assess solid tumors or suspected masses.
1 to 3 imaging visits depending on available modalities
Duration - Up to 12 months
Participants are monitored for tumor number and metabolic activity over time following imaging assessments.
Follow-up visits as determined by treating physicians
Trial Site Locations
Total: 1 location
1
Stanford University, School of Medicine
Palo Alto, California, United States, 94304
Actively Recruiting
Research Team
A
Anne Muehe
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here